World is Off Track to Meet ‘Triple Billion’ Health Targets 07/05/2024 Kerry Cullinan “The world is off track to reach most of the Triple Billion targets and the health-related Sustainable Development Goals,” said World Health Organization (WHO) Director General Dr Tedros Adhanom Ghebreyesus. His comments were part of the WHO Results Report 2023 released on Tuesday. The triple billion targets involve one billion more people benefitting from universal […] Continue reading -> Unlocking the Potential of Pharmacogenomics in Africa 25/04/2024 Kelly Chibale Pharmacogenomics research in Africa transcends mere regional healthcare improvements: it represents a pivotal step in addressing pressing global health challenges and propelling medical science forward for all. A revolution is sweeping through the field of medicine, redefining how we approach the treatment of diseases. Africa must not be left behind in this transformative journey. Pharmacogenomics, […] Continue reading -> Immunisation Saved At Least 154 Million Lives Over Past 50 Years – WHO 24/04/2024 Kerry Cullinan Immunisation has saved at least 154 million lives over the past 50 years, since the World Health Organization (WHO) launched its Expanded Programme on Immunization (EPI) in 1974. Of the lives saved, 146 million were children under five, and 101 million were babies. Global infant deaths have reduced by 40% and more than halved in […] Continue reading -> New WHO Terminology to Clear Confusion over ‘Airborne’ Pathogens 19/04/2024 Kerry Cullinan The World Health Organization (WHO) has published a new technical report including updated terminology to describe pathogens that are transmitted through the air, following “an extensive, multi-year, collaborative effort”. It follows confusion and contestation between scientists during the COVID-19 pandemic because of the “varying terminologies” and “gaps in common understanding”, said the WHO. These “contributed […] Continue reading -> Deaths from Viral Hepatitis Increase Globally With Limited Access to Diagnostics and Treatment 09/04/2024 Kerry Cullinan There has been an increase in deaths from hepatitis B and C, the infectious viral liver diseases that kill as many people each year as tuberculosis – yet few people know that they are infected and get the treatment they need. This is according to the World Health Organization (WHO) 2024 Global Hepatitis Report – […] Continue reading -> Mpox: Is the World Failing the Next Pandemic Preparedness Litmus Test? 02/04/2024 Jean-Jacques Muyembe Tamfum, Dimie Ogoina, Francine Ntoumi, Nathalie Strub Wourgaft, Samba Sow, Spring Gombe & Jessica Ilunga At a time when the world is negotiating the best way forward for sustained preparedness to address pandemics, it is still exhibiting collective failure to learn from past outbreaks and a glaring gap in global health security. Mpox is one case in point – and a test case for global intent on pandemic preparedness. In […] Continue reading -> Fight Against TB Gets Boost From Artificial Intelligence and Innovative Financing 21/03/2024 Kerry Cullinan Tuberculosis has long been the neglected stepchild of global health – but new diagnostic tools and treatments, artificial intelligence (AI) and debt swaps to help countries meet their targets have come into play and are making a difference. “There is fresh momentum,” says Dr Jamie Tonsing, Senior TB advisor at the Global Fund, in a […] Continue reading -> Wake-Up Call: Lessons Learned from Poland must Reaffirm TB as an EU Health Priority 21/03/2024 Krzysztof Herboczek & Joanna Ladomirska Over the last century, Europe – including Northern, Western, Southern and Central European countries – made remarkable progress in the near elimination of tuberculosis (TB) due to improved socio-economic conditions and advancements in research and development. However, a recent surge of TB in Europe, coupled with lack of structural preparedness within many European Union (EU) […] Continue reading -> TB Vaccine Phase 3 Trial Launched, as WHO Makes Case for Investing in Screening and Prevention 20/03/2024 Disha Shetty A Phase 3 trial of a tuberculosis vaccine candidate has been launched in South Africa, according to the Bill & Melinda Gates Medical Research Institute (Gates MRI). The candidate vaccine – referred to as M72/AS01E – “could potentially become the first vaccine to help prevent pulmonary TB in adolescents and adults, the most common form […] Continue reading -> WHO Assurance on Drug Resistance to Key HIV Drug, Dolutegravir; New Trial Shows Promise With TB Treatment 14/03/2024 Kerry Cullinan The World Health Organization (WHO) recently reported drug resistance to the world’s gold-standard antiretroviral medicine, dolutegravir “exceeding levels observed in clinical trials” – with resistance ranging from 3.9% to 19.6%. This was potentially very bad news as dolutegravir has been the recommended first- and second-line HIV treatment for all population groups since 2018 – but […] Continue reading -> Posts navigation Older postsNewer posts
Unlocking the Potential of Pharmacogenomics in Africa 25/04/2024 Kelly Chibale Pharmacogenomics research in Africa transcends mere regional healthcare improvements: it represents a pivotal step in addressing pressing global health challenges and propelling medical science forward for all. A revolution is sweeping through the field of medicine, redefining how we approach the treatment of diseases. Africa must not be left behind in this transformative journey. Pharmacogenomics, […] Continue reading -> Immunisation Saved At Least 154 Million Lives Over Past 50 Years – WHO 24/04/2024 Kerry Cullinan Immunisation has saved at least 154 million lives over the past 50 years, since the World Health Organization (WHO) launched its Expanded Programme on Immunization (EPI) in 1974. Of the lives saved, 146 million were children under five, and 101 million were babies. Global infant deaths have reduced by 40% and more than halved in […] Continue reading -> New WHO Terminology to Clear Confusion over ‘Airborne’ Pathogens 19/04/2024 Kerry Cullinan The World Health Organization (WHO) has published a new technical report including updated terminology to describe pathogens that are transmitted through the air, following “an extensive, multi-year, collaborative effort”. It follows confusion and contestation between scientists during the COVID-19 pandemic because of the “varying terminologies” and “gaps in common understanding”, said the WHO. These “contributed […] Continue reading -> Deaths from Viral Hepatitis Increase Globally With Limited Access to Diagnostics and Treatment 09/04/2024 Kerry Cullinan There has been an increase in deaths from hepatitis B and C, the infectious viral liver diseases that kill as many people each year as tuberculosis – yet few people know that they are infected and get the treatment they need. This is according to the World Health Organization (WHO) 2024 Global Hepatitis Report – […] Continue reading -> Mpox: Is the World Failing the Next Pandemic Preparedness Litmus Test? 02/04/2024 Jean-Jacques Muyembe Tamfum, Dimie Ogoina, Francine Ntoumi, Nathalie Strub Wourgaft, Samba Sow, Spring Gombe & Jessica Ilunga At a time when the world is negotiating the best way forward for sustained preparedness to address pandemics, it is still exhibiting collective failure to learn from past outbreaks and a glaring gap in global health security. Mpox is one case in point – and a test case for global intent on pandemic preparedness. In […] Continue reading -> Fight Against TB Gets Boost From Artificial Intelligence and Innovative Financing 21/03/2024 Kerry Cullinan Tuberculosis has long been the neglected stepchild of global health – but new diagnostic tools and treatments, artificial intelligence (AI) and debt swaps to help countries meet their targets have come into play and are making a difference. “There is fresh momentum,” says Dr Jamie Tonsing, Senior TB advisor at the Global Fund, in a […] Continue reading -> Wake-Up Call: Lessons Learned from Poland must Reaffirm TB as an EU Health Priority 21/03/2024 Krzysztof Herboczek & Joanna Ladomirska Over the last century, Europe – including Northern, Western, Southern and Central European countries – made remarkable progress in the near elimination of tuberculosis (TB) due to improved socio-economic conditions and advancements in research and development. However, a recent surge of TB in Europe, coupled with lack of structural preparedness within many European Union (EU) […] Continue reading -> TB Vaccine Phase 3 Trial Launched, as WHO Makes Case for Investing in Screening and Prevention 20/03/2024 Disha Shetty A Phase 3 trial of a tuberculosis vaccine candidate has been launched in South Africa, according to the Bill & Melinda Gates Medical Research Institute (Gates MRI). The candidate vaccine – referred to as M72/AS01E – “could potentially become the first vaccine to help prevent pulmonary TB in adolescents and adults, the most common form […] Continue reading -> WHO Assurance on Drug Resistance to Key HIV Drug, Dolutegravir; New Trial Shows Promise With TB Treatment 14/03/2024 Kerry Cullinan The World Health Organization (WHO) recently reported drug resistance to the world’s gold-standard antiretroviral medicine, dolutegravir “exceeding levels observed in clinical trials” – with resistance ranging from 3.9% to 19.6%. This was potentially very bad news as dolutegravir has been the recommended first- and second-line HIV treatment for all population groups since 2018 – but […] Continue reading -> Posts navigation Older postsNewer posts
Immunisation Saved At Least 154 Million Lives Over Past 50 Years – WHO 24/04/2024 Kerry Cullinan Immunisation has saved at least 154 million lives over the past 50 years, since the World Health Organization (WHO) launched its Expanded Programme on Immunization (EPI) in 1974. Of the lives saved, 146 million were children under five, and 101 million were babies. Global infant deaths have reduced by 40% and more than halved in […] Continue reading -> New WHO Terminology to Clear Confusion over ‘Airborne’ Pathogens 19/04/2024 Kerry Cullinan The World Health Organization (WHO) has published a new technical report including updated terminology to describe pathogens that are transmitted through the air, following “an extensive, multi-year, collaborative effort”. It follows confusion and contestation between scientists during the COVID-19 pandemic because of the “varying terminologies” and “gaps in common understanding”, said the WHO. These “contributed […] Continue reading -> Deaths from Viral Hepatitis Increase Globally With Limited Access to Diagnostics and Treatment 09/04/2024 Kerry Cullinan There has been an increase in deaths from hepatitis B and C, the infectious viral liver diseases that kill as many people each year as tuberculosis – yet few people know that they are infected and get the treatment they need. This is according to the World Health Organization (WHO) 2024 Global Hepatitis Report – […] Continue reading -> Mpox: Is the World Failing the Next Pandemic Preparedness Litmus Test? 02/04/2024 Jean-Jacques Muyembe Tamfum, Dimie Ogoina, Francine Ntoumi, Nathalie Strub Wourgaft, Samba Sow, Spring Gombe & Jessica Ilunga At a time when the world is negotiating the best way forward for sustained preparedness to address pandemics, it is still exhibiting collective failure to learn from past outbreaks and a glaring gap in global health security. Mpox is one case in point – and a test case for global intent on pandemic preparedness. In […] Continue reading -> Fight Against TB Gets Boost From Artificial Intelligence and Innovative Financing 21/03/2024 Kerry Cullinan Tuberculosis has long been the neglected stepchild of global health – but new diagnostic tools and treatments, artificial intelligence (AI) and debt swaps to help countries meet their targets have come into play and are making a difference. “There is fresh momentum,” says Dr Jamie Tonsing, Senior TB advisor at the Global Fund, in a […] Continue reading -> Wake-Up Call: Lessons Learned from Poland must Reaffirm TB as an EU Health Priority 21/03/2024 Krzysztof Herboczek & Joanna Ladomirska Over the last century, Europe – including Northern, Western, Southern and Central European countries – made remarkable progress in the near elimination of tuberculosis (TB) due to improved socio-economic conditions and advancements in research and development. However, a recent surge of TB in Europe, coupled with lack of structural preparedness within many European Union (EU) […] Continue reading -> TB Vaccine Phase 3 Trial Launched, as WHO Makes Case for Investing in Screening and Prevention 20/03/2024 Disha Shetty A Phase 3 trial of a tuberculosis vaccine candidate has been launched in South Africa, according to the Bill & Melinda Gates Medical Research Institute (Gates MRI). The candidate vaccine – referred to as M72/AS01E – “could potentially become the first vaccine to help prevent pulmonary TB in adolescents and adults, the most common form […] Continue reading -> WHO Assurance on Drug Resistance to Key HIV Drug, Dolutegravir; New Trial Shows Promise With TB Treatment 14/03/2024 Kerry Cullinan The World Health Organization (WHO) recently reported drug resistance to the world’s gold-standard antiretroviral medicine, dolutegravir “exceeding levels observed in clinical trials” – with resistance ranging from 3.9% to 19.6%. This was potentially very bad news as dolutegravir has been the recommended first- and second-line HIV treatment for all population groups since 2018 – but […] Continue reading -> Posts navigation Older postsNewer posts
New WHO Terminology to Clear Confusion over ‘Airborne’ Pathogens 19/04/2024 Kerry Cullinan The World Health Organization (WHO) has published a new technical report including updated terminology to describe pathogens that are transmitted through the air, following “an extensive, multi-year, collaborative effort”. It follows confusion and contestation between scientists during the COVID-19 pandemic because of the “varying terminologies” and “gaps in common understanding”, said the WHO. These “contributed […] Continue reading -> Deaths from Viral Hepatitis Increase Globally With Limited Access to Diagnostics and Treatment 09/04/2024 Kerry Cullinan There has been an increase in deaths from hepatitis B and C, the infectious viral liver diseases that kill as many people each year as tuberculosis – yet few people know that they are infected and get the treatment they need. This is according to the World Health Organization (WHO) 2024 Global Hepatitis Report – […] Continue reading -> Mpox: Is the World Failing the Next Pandemic Preparedness Litmus Test? 02/04/2024 Jean-Jacques Muyembe Tamfum, Dimie Ogoina, Francine Ntoumi, Nathalie Strub Wourgaft, Samba Sow, Spring Gombe & Jessica Ilunga At a time when the world is negotiating the best way forward for sustained preparedness to address pandemics, it is still exhibiting collective failure to learn from past outbreaks and a glaring gap in global health security. Mpox is one case in point – and a test case for global intent on pandemic preparedness. In […] Continue reading -> Fight Against TB Gets Boost From Artificial Intelligence and Innovative Financing 21/03/2024 Kerry Cullinan Tuberculosis has long been the neglected stepchild of global health – but new diagnostic tools and treatments, artificial intelligence (AI) and debt swaps to help countries meet their targets have come into play and are making a difference. “There is fresh momentum,” says Dr Jamie Tonsing, Senior TB advisor at the Global Fund, in a […] Continue reading -> Wake-Up Call: Lessons Learned from Poland must Reaffirm TB as an EU Health Priority 21/03/2024 Krzysztof Herboczek & Joanna Ladomirska Over the last century, Europe – including Northern, Western, Southern and Central European countries – made remarkable progress in the near elimination of tuberculosis (TB) due to improved socio-economic conditions and advancements in research and development. However, a recent surge of TB in Europe, coupled with lack of structural preparedness within many European Union (EU) […] Continue reading -> TB Vaccine Phase 3 Trial Launched, as WHO Makes Case for Investing in Screening and Prevention 20/03/2024 Disha Shetty A Phase 3 trial of a tuberculosis vaccine candidate has been launched in South Africa, according to the Bill & Melinda Gates Medical Research Institute (Gates MRI). The candidate vaccine – referred to as M72/AS01E – “could potentially become the first vaccine to help prevent pulmonary TB in adolescents and adults, the most common form […] Continue reading -> WHO Assurance on Drug Resistance to Key HIV Drug, Dolutegravir; New Trial Shows Promise With TB Treatment 14/03/2024 Kerry Cullinan The World Health Organization (WHO) recently reported drug resistance to the world’s gold-standard antiretroviral medicine, dolutegravir “exceeding levels observed in clinical trials” – with resistance ranging from 3.9% to 19.6%. This was potentially very bad news as dolutegravir has been the recommended first- and second-line HIV treatment for all population groups since 2018 – but […] Continue reading -> Posts navigation Older postsNewer posts
Deaths from Viral Hepatitis Increase Globally With Limited Access to Diagnostics and Treatment 09/04/2024 Kerry Cullinan There has been an increase in deaths from hepatitis B and C, the infectious viral liver diseases that kill as many people each year as tuberculosis – yet few people know that they are infected and get the treatment they need. This is according to the World Health Organization (WHO) 2024 Global Hepatitis Report – […] Continue reading -> Mpox: Is the World Failing the Next Pandemic Preparedness Litmus Test? 02/04/2024 Jean-Jacques Muyembe Tamfum, Dimie Ogoina, Francine Ntoumi, Nathalie Strub Wourgaft, Samba Sow, Spring Gombe & Jessica Ilunga At a time when the world is negotiating the best way forward for sustained preparedness to address pandemics, it is still exhibiting collective failure to learn from past outbreaks and a glaring gap in global health security. Mpox is one case in point – and a test case for global intent on pandemic preparedness. In […] Continue reading -> Fight Against TB Gets Boost From Artificial Intelligence and Innovative Financing 21/03/2024 Kerry Cullinan Tuberculosis has long been the neglected stepchild of global health – but new diagnostic tools and treatments, artificial intelligence (AI) and debt swaps to help countries meet their targets have come into play and are making a difference. “There is fresh momentum,” says Dr Jamie Tonsing, Senior TB advisor at the Global Fund, in a […] Continue reading -> Wake-Up Call: Lessons Learned from Poland must Reaffirm TB as an EU Health Priority 21/03/2024 Krzysztof Herboczek & Joanna Ladomirska Over the last century, Europe – including Northern, Western, Southern and Central European countries – made remarkable progress in the near elimination of tuberculosis (TB) due to improved socio-economic conditions and advancements in research and development. However, a recent surge of TB in Europe, coupled with lack of structural preparedness within many European Union (EU) […] Continue reading -> TB Vaccine Phase 3 Trial Launched, as WHO Makes Case for Investing in Screening and Prevention 20/03/2024 Disha Shetty A Phase 3 trial of a tuberculosis vaccine candidate has been launched in South Africa, according to the Bill & Melinda Gates Medical Research Institute (Gates MRI). The candidate vaccine – referred to as M72/AS01E – “could potentially become the first vaccine to help prevent pulmonary TB in adolescents and adults, the most common form […] Continue reading -> WHO Assurance on Drug Resistance to Key HIV Drug, Dolutegravir; New Trial Shows Promise With TB Treatment 14/03/2024 Kerry Cullinan The World Health Organization (WHO) recently reported drug resistance to the world’s gold-standard antiretroviral medicine, dolutegravir “exceeding levels observed in clinical trials” – with resistance ranging from 3.9% to 19.6%. This was potentially very bad news as dolutegravir has been the recommended first- and second-line HIV treatment for all population groups since 2018 – but […] Continue reading -> Posts navigation Older postsNewer posts
Mpox: Is the World Failing the Next Pandemic Preparedness Litmus Test? 02/04/2024 Jean-Jacques Muyembe Tamfum, Dimie Ogoina, Francine Ntoumi, Nathalie Strub Wourgaft, Samba Sow, Spring Gombe & Jessica Ilunga At a time when the world is negotiating the best way forward for sustained preparedness to address pandemics, it is still exhibiting collective failure to learn from past outbreaks and a glaring gap in global health security. Mpox is one case in point – and a test case for global intent on pandemic preparedness. In […] Continue reading -> Fight Against TB Gets Boost From Artificial Intelligence and Innovative Financing 21/03/2024 Kerry Cullinan Tuberculosis has long been the neglected stepchild of global health – but new diagnostic tools and treatments, artificial intelligence (AI) and debt swaps to help countries meet their targets have come into play and are making a difference. “There is fresh momentum,” says Dr Jamie Tonsing, Senior TB advisor at the Global Fund, in a […] Continue reading -> Wake-Up Call: Lessons Learned from Poland must Reaffirm TB as an EU Health Priority 21/03/2024 Krzysztof Herboczek & Joanna Ladomirska Over the last century, Europe – including Northern, Western, Southern and Central European countries – made remarkable progress in the near elimination of tuberculosis (TB) due to improved socio-economic conditions and advancements in research and development. However, a recent surge of TB in Europe, coupled with lack of structural preparedness within many European Union (EU) […] Continue reading -> TB Vaccine Phase 3 Trial Launched, as WHO Makes Case for Investing in Screening and Prevention 20/03/2024 Disha Shetty A Phase 3 trial of a tuberculosis vaccine candidate has been launched in South Africa, according to the Bill & Melinda Gates Medical Research Institute (Gates MRI). The candidate vaccine – referred to as M72/AS01E – “could potentially become the first vaccine to help prevent pulmonary TB in adolescents and adults, the most common form […] Continue reading -> WHO Assurance on Drug Resistance to Key HIV Drug, Dolutegravir; New Trial Shows Promise With TB Treatment 14/03/2024 Kerry Cullinan The World Health Organization (WHO) recently reported drug resistance to the world’s gold-standard antiretroviral medicine, dolutegravir “exceeding levels observed in clinical trials” – with resistance ranging from 3.9% to 19.6%. This was potentially very bad news as dolutegravir has been the recommended first- and second-line HIV treatment for all population groups since 2018 – but […] Continue reading -> Posts navigation Older postsNewer posts
Fight Against TB Gets Boost From Artificial Intelligence and Innovative Financing 21/03/2024 Kerry Cullinan Tuberculosis has long been the neglected stepchild of global health – but new diagnostic tools and treatments, artificial intelligence (AI) and debt swaps to help countries meet their targets have come into play and are making a difference. “There is fresh momentum,” says Dr Jamie Tonsing, Senior TB advisor at the Global Fund, in a […] Continue reading -> Wake-Up Call: Lessons Learned from Poland must Reaffirm TB as an EU Health Priority 21/03/2024 Krzysztof Herboczek & Joanna Ladomirska Over the last century, Europe – including Northern, Western, Southern and Central European countries – made remarkable progress in the near elimination of tuberculosis (TB) due to improved socio-economic conditions and advancements in research and development. However, a recent surge of TB in Europe, coupled with lack of structural preparedness within many European Union (EU) […] Continue reading -> TB Vaccine Phase 3 Trial Launched, as WHO Makes Case for Investing in Screening and Prevention 20/03/2024 Disha Shetty A Phase 3 trial of a tuberculosis vaccine candidate has been launched in South Africa, according to the Bill & Melinda Gates Medical Research Institute (Gates MRI). The candidate vaccine – referred to as M72/AS01E – “could potentially become the first vaccine to help prevent pulmonary TB in adolescents and adults, the most common form […] Continue reading -> WHO Assurance on Drug Resistance to Key HIV Drug, Dolutegravir; New Trial Shows Promise With TB Treatment 14/03/2024 Kerry Cullinan The World Health Organization (WHO) recently reported drug resistance to the world’s gold-standard antiretroviral medicine, dolutegravir “exceeding levels observed in clinical trials” – with resistance ranging from 3.9% to 19.6%. This was potentially very bad news as dolutegravir has been the recommended first- and second-line HIV treatment for all population groups since 2018 – but […] Continue reading -> Posts navigation Older postsNewer posts
Wake-Up Call: Lessons Learned from Poland must Reaffirm TB as an EU Health Priority 21/03/2024 Krzysztof Herboczek & Joanna Ladomirska Over the last century, Europe – including Northern, Western, Southern and Central European countries – made remarkable progress in the near elimination of tuberculosis (TB) due to improved socio-economic conditions and advancements in research and development. However, a recent surge of TB in Europe, coupled with lack of structural preparedness within many European Union (EU) […] Continue reading -> TB Vaccine Phase 3 Trial Launched, as WHO Makes Case for Investing in Screening and Prevention 20/03/2024 Disha Shetty A Phase 3 trial of a tuberculosis vaccine candidate has been launched in South Africa, according to the Bill & Melinda Gates Medical Research Institute (Gates MRI). The candidate vaccine – referred to as M72/AS01E – “could potentially become the first vaccine to help prevent pulmonary TB in adolescents and adults, the most common form […] Continue reading -> WHO Assurance on Drug Resistance to Key HIV Drug, Dolutegravir; New Trial Shows Promise With TB Treatment 14/03/2024 Kerry Cullinan The World Health Organization (WHO) recently reported drug resistance to the world’s gold-standard antiretroviral medicine, dolutegravir “exceeding levels observed in clinical trials” – with resistance ranging from 3.9% to 19.6%. This was potentially very bad news as dolutegravir has been the recommended first- and second-line HIV treatment for all population groups since 2018 – but […] Continue reading -> Posts navigation Older postsNewer posts
TB Vaccine Phase 3 Trial Launched, as WHO Makes Case for Investing in Screening and Prevention 20/03/2024 Disha Shetty A Phase 3 trial of a tuberculosis vaccine candidate has been launched in South Africa, according to the Bill & Melinda Gates Medical Research Institute (Gates MRI). The candidate vaccine – referred to as M72/AS01E – “could potentially become the first vaccine to help prevent pulmonary TB in adolescents and adults, the most common form […] Continue reading -> WHO Assurance on Drug Resistance to Key HIV Drug, Dolutegravir; New Trial Shows Promise With TB Treatment 14/03/2024 Kerry Cullinan The World Health Organization (WHO) recently reported drug resistance to the world’s gold-standard antiretroviral medicine, dolutegravir “exceeding levels observed in clinical trials” – with resistance ranging from 3.9% to 19.6%. This was potentially very bad news as dolutegravir has been the recommended first- and second-line HIV treatment for all population groups since 2018 – but […] Continue reading -> Posts navigation Older postsNewer posts
WHO Assurance on Drug Resistance to Key HIV Drug, Dolutegravir; New Trial Shows Promise With TB Treatment 14/03/2024 Kerry Cullinan The World Health Organization (WHO) recently reported drug resistance to the world’s gold-standard antiretroviral medicine, dolutegravir “exceeding levels observed in clinical trials” – with resistance ranging from 3.9% to 19.6%. This was potentially very bad news as dolutegravir has been the recommended first- and second-line HIV treatment for all population groups since 2018 – but […] Continue reading -> Posts navigation Older postsNewer posts